[SCHEDULE 13G] AtriCure, Inc. Passive Investment Disclosure (>5%)
Rhea-AI Filing Summary
AtriCure Inc reports an institutional holding: Vanguard Capital Management beneficially owns 2,532,965 shares of common stock, representing 5.08% of the class.
The Schedule 13G lists voting and dispositive powers: sole power to vote 377,201 shares and sole dispositive power over 2,532,965 shares. The filing names affiliated Vanguard entities and is signed by a Vanguard officer.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a passive >5% stake with dispositive authority across multiple affiliated accounts.
The filing shows 2,532,965 shares (5.08%) beneficially owned by Vanguard Capital Management and affiliated divisions. The filer reports sole dispositive power over the full holding and sole voting power over 377,201 shares, consistent with consolidated reporting of managed funds.
Because this is a Schedule 13G filing, the position is presented as passive under the filer’s reporting status. Subsequent disclosures would appear if the holder’s intent or voting role changes.